OBIO - Orchestra BioMed Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.50
DETAILS
HIGH:
$13.00
LOW:
$10.00
MEDIAN:
$11.50
CONSENSUS:
$11.50
UPSIDE:
103.18%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue | 33.5 | 2.6 | 2.8 | 3.5 | (0.8) | 5.7 |
| Cost of Revenue | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.1 |
| Gross Profit | 33.3 | 2.4 | 2.6 | 3.2 | (1.0) | 5.6 |
| Operating Expenses | ||||||
| R&D Expenses | 58.2 | 42.8 | 33.8 | 21.9 | 12.9 | 13.5 |
| SG&A Expenses | 26.9 | 23.9 | 20.3 | 13.9 | 7.9 | 10.8 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 85.1 | 66.7 | 54.1 | 35.9 | 20.8 | 24.3 |
| Operating Income | ||||||
| Operating Income | (51.8) | (64.3) | (51.5) | (32.7) | (21.8) | (18.8) |
| Interest Expense | 1.1 | 0 | 0 | 0 | 0.9 | 0 |
| Interest Income | 0 | 3.4 | 3.8 | 0.1 | 0 | 0.3 |
| Profitability | ||||||
| EBITDA | (51.2) | (60.7) | (48.8) | (33.4) | (21.9) | (18.6) |
| EBIT | (51.6) | (61.0) | (49.1) | (33.6) | (22.1) | (18.8) |
| Income Before Tax | (52.7) | (61.0) | (49.1) | (33.6) | (23.0) | (21.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (52.7) | (61.0) | (49.1) | (33.6) | (23.0) | (21.4) |
| Per Share Data | ||||||
| EPS (Basic) | -1.11 | -1.66 | -1.48 | -1.32 | -0.02 | -0.01 |
| EPS (Diluted) | -1.11 | -1.66 | -1.48 | -1.32 | -0.02 | -0.01 |
| Shares Outstanding | 47.7 | 36.8 | 33.2 | 25.5 | 20.4 | 20.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Current Assets | ||||||
| Cash & Cash Equivalents | 34.7 | 22.3 | 30.6 | 19.8 | 9.9 | 20.3 |
| Short-Term Investments | 71.8 | 44.6 | 57.0 | 64.0 | 1.0 | 15.4 |
| Net Receivables | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Inventory | 0.3 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 |
| Other Current Assets | 1.0 | 2.1 | 1.3 | 0.5 | 0 | 0 |
| Total Current Assets | 107.9 | 69.2 | 89.1 | 84.7 | 11.3 | 36.3 |
| Non-Current Assets | ||||||
| Property, Plant & Equipment | 3.2 | 3.5 | 2.8 | 3.7 | 1.1 | 1.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 2.5 | 2.5 | 2.5 | 2.5 | 0.4 | 0.2 |
| Other Non-Current Assets | 1.2 | 1.0 | 0.8 | 4.7 | 0.7 | 0.6 |
| Total Non-Current Assets | 6.9 | 7.0 | 6.1 | 10.9 | 2.2 | 1.8 |
| Total Assets | 114.9 | 76.2 | 95.2 | 95.6 | 13.5 | 38.1 |
| Current Liabilities | ||||||
| Account Payables | 6.1 | 5.1 | 2.9 | 4.0 | 2.0 | 1.8 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 2 | 4 |
| Deferred Revenue | 0 | 4.4 | 2.5 | 6.4 | 5.5 | 5.8 |
| Other Current Liabilities | 4.2 | 2.6 | 2.7 | 4.6 | 2.0 | 2.2 |
| Total Current Liabilities | 16.7 | 16.2 | 11.2 | 18.6 | 12.2 | 14.4 |
| Non-Current Liabilities | ||||||
| Long-Term Debt | 14.3 | 14.3 | 0 | 9.5 | 3.7 | 5.5 |
| Deferred Tax Liabilities | 0 | 0 | (14.9) | 0 | 0 | 0 |
| Other Non-Current Liabilities | 19.5 | 0.0 | 14.9 | 0.2 | 52.0 | 51.7 |
| Total Non-Current Liabilities | 34.7 | 27.0 | 16.0 | 24.5 | 72.5 | 72.3 |
| Total Liabilities | 51.5 | 43.2 | 27.2 | 43.0 | 84.8 | 86.6 |
| Stockholders' Equity | ||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 160.0 | 0 |
| Retained Earnings | (362.6) | (309.9) | (248.9) | (199.7) | (166.1) | (143.1) |
| Accumulated Other Comprehensive Income | 0.1 | 0.1 | (0.0) | (0.0) | (211.5) | (0.0) |
| Total Stockholders' Equity | 63.4 | 33.0 | 68.0 | 52.5 | (71.2) | (48.5) |
| Total Liabilities & Equity | 114.9 | 76.2 | 95.2 | 95.6 | 13.5 | 38.1 |
| Debt Metrics | ||||||
| Total Debt | 16.0 | 16.5 | 1.7 | 11.9 | 5.7 | 9.5 |
| Net Debt | (18.7) | (5.7) | (28.9) | (7.9) | (4.3) | (10.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | (52.7) | (61.0) | (49.1) | (33.6) | (23.0) | (21.4) |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.1 |
| Stock-Based Compensation | 12.0 | 10.6 | 7.6 | 3.4 | 0.3 | 0.2 |
| Change in Working Capital | (10.4) | (0.8) | (3.3) | (0.5) | 2.6 | (8.1) |
| Other Non-Cash Items | 1.8 | 0.3 | (1.6) | 1.1 | 0.2 | 2.9 |
| Operating Cash Flow | (49.0) | (50.6) | (46.1) | (29.3) | (19.4) | (26.2) |
| Investing Activities | ||||||
| Capital Expenditure | (0.5) | (0.3) | (0.1) | (0.6) | (0.3) | (0.5) |
| Acquisitions | 0 | (0.6) | 0 | 0 | (13.3) | (27.5) |
| Purchases of Investments | (76.3) | (72.6) | (142.0) | (63.5) | (0.2) | (15.6) |
| Sales/Maturities of Investments | 49.9 | 86.6 | 152.8 | 0 | 13.5 | 43.1 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 13.3 | 27.5 |
| Investing Cash Flow | (26.9) | 13.1 | 10.7 | (64.1) | 13.0 | 27.0 |
| Financing Activities | ||||||
| Net Debt Issuance | 17.9 | 15 | (10.8) | 3.6 | (4) | 10 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.6) | (0.9) | 56.8 | (10.1) | 0.0 | (162.3) |
| Financing Cash Flow | 88.3 | 29.2 | 46.2 | 103.3 | (4.0) | 10 |
| Cash Position | ||||||
| Net Change in Cash | 12.4 | (8.3) | 10.8 | 9.8 | (10.4) | 10.8 |
| Cash at Beginning | 22.3 | 30.6 | 19.8 | 9.9 | 20.3 | 9.6 |
| Cash at End | 34.7 | 22.3 | 30.6 | 19.8 | 9.9 | 20.3 |
| Free Cash Flow | (49.5) | (50.8) | (46.2) | (29.9) | (19.7) | (26.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 33.5 | 2.6 | 2.8 | 3.5 | (0.8) | 5.7 |
| Gross Profit | 33.3 | 2.4 | 2.6 | 3.2 | (1.0) | 5.6 |
| Operating Income | (51.8) | (64.3) | (51.5) | (32.7) | (21.8) | (18.8) |
| Net Income | (52.7) | (61.0) | (49.1) | (33.6) | (23.0) | (21.4) |
| EPS (Diluted) | -1.11 | -1.66 | -1.48 | -1.32 | -0.02 | -0.01 |
| Balance Sheet | ||||||
| Cash & Equivalents | 34.7 | 22.3 | 30.6 | 19.8 | 9.9 | 20.3 |
| Total Assets | 114.9 | 76.2 | 95.2 | 95.6 | 13.5 | 38.1 |
| Total Debt | 16.0 | 16.5 | 1.7 | 11.9 | 5.7 | 9.5 |
| Stockholders' Equity | 63.4 | 33.0 | 68.0 | 52.5 | (71.2) | (48.5) |
| Cash Flow | ||||||
| Operating Cash Flow | (49.0) | (50.6) | (46.1) | (29.3) | (19.4) | (26.2) |
| Capital Expenditure | (0.5) | (0.3) | (0.1) | (0.6) | (0.3) | (0.5) |
| Free Cash Flow | (49.5) | (50.8) | (46.2) | (29.9) | (19.7) | (26.7) |